Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
Current Drug Targets|August 26, 2015
Targeting the Eph-ephrin System with Protein-Protein Interaction (PPI) InhibitorsMassimiliano Tognolini, Alessio LodolaBritish Journal of Pharmacology|October 23, 2023
Drug discovery: In silico dry data can bypass biological wet data?Massimiliano Tognolini, Alessio Lodola, Carmine GiorgioACS Chemical Neuroscience|November 19, 2014
Are we using the right pharmacological tools to target EphA4?Massimiliano Tognolini, Matteo Incerti, Alessio LodolaExpert Opinion on Therapeutic Targets|March 22, 2020
Ephrin or not? Six tough questions on Eph targetingCarmine Giorgio, Ilaria Zanotti, Alessio Lodola, et al.Drug Discovery Today|June 2, 2018
Mesenteric ischemia-reperfusion: an overview of preclinical drug strategiesSimona Bertoni, Vigilio Ballabeni, Elisabetta Barocelli, et al.Expert Opinion on Therapeutic Patents|September 11, 2024
Ephrin receptor type-A2 (EphA2) targeting in cancer: a patent review (2018-present)Massimiliano Tognolini, Francesca Romana Ferrari, Alfonso Zappia, et al.European Journal of Medicinal Chemistry|August 7, 2017
Targeting Eph/ephrin system in cancer therapyAlessio Lodola, Carmine Giorgio, Matteo Incerti, et al.Drug Discovery Today|December 3, 2013
Therapeutic perspectives of Eph-ephrin system modulationMassimiliano Tognolini, Iftiin Hassan-Mohamed, Carmine Giorgio, et al.Fitoterapia|October 15, 2009
Ocotea quixos Lam. essential oil: in vitro and in vivo investigation on its anti-inflammatory propertiesVigilio Ballabeni, Massimiliano Tognolini, Carmine Giorgio, et al.International Immunopharmacology|January 11, 2026
Target validation of natural compounds: Perillaldehyde case studyAndrea Blesio, Carmine Giorgio, Stefano Sala, et al.Pageof 8